Encapsulating gold nanomaterials into size-controlled human serum albumin nanoparticles for cancer therapy platforms

References

• Alkilany AM, Thompson LB, Boulos SP, Sisco PN, Murphy CJ. Gold nanorods: Their potential for photothermal therapeutics and drug delivery, tempered by the complexity of their biological interactions. Adv Drug Deliv Rev, 2012;64:190–9
   PubMed Web of Science ®Google Scholar
• Anhorn MG, Wagner S, Kreuter J, Langer K, Von Briesen H. Specific targeting of HER2 overexpressing breast cancer cells with doxorubicin-loaded trastuzumab-modified human serum albumin nanoparticles. Bioconjugate Chem, 2008;19:2321–31
   PubMed Web of Science ®Google Scholar
• Bardhan R, Grady NK, Cole JR, Joshi A, Halas NJ. Fluorescence enhancement by Au nanostructures: Nanoshells and nanorods. ACS Nano, 2009;3:744–52
   PubMed Web of Science ®Google Scholar
• Bardhan R, Lal S, Joshi A, Halas NJ. Theranostic nanoshells: From probe design to imaging and treatment of cancer. Acc Chem Res, 2011;44:936–46
   PubMed Web of Science ®Google Scholar
• Cañaveras F, Madueño R, Sevilla JM, Blázquez M, Pineda T. Role of the functionalization of the gold nanoparticle surface on the formation of bioconjugates with human serum albumin. J Phys Chem C, 2012;116:10430–7
   Web of Science ®Google Scholar
• Charan S, Sanjiv K, Singh N, Chien F-C, Chen Y-F, Nergui NN, Huang S, Kuo CW, Lee T-C, Chen P. Development of chitosan oligosaccharide-modified gold nanorods for in vivo targeted delivery and noninvasive imaging by NIR irradiation. Bioconjug Chem, 2012;23:2173–82
   PubMed Web of Science ®Google Scholar
• Choi J, Yang J, Jang E, Suh J, Huh Y, Lee K, Haam S. Gold nanostructures as photothermal therapy agent for cancer. Anti-Cancer Agents Med Chem, 2011a;11:953–64
   PubMed Web of Science ®Google Scholar
• Choi WI, Kim JY, Kang C, Byeon CC, Kim YH, Tae G. Tumor regression in vivo by photothermal therapy based on gold-nanorod-loaded, functional nanocarriers. ACS Nano, 2011b;5:1995–2003
   PubMed Web of Science ®Google Scholar
• Cole JR, Mirin NA, Knight MW, Goodrich GP, Halas NJ. Photothermal efficiencies of nanoshells and nanorods for clinical therapeutic applications. J Phys Chem, 2009;113:12090–4
   Web of Science ®Google Scholar
• Dreis S, Rothweiler F, Michaelis M, Cinatl Jr J, Kreuter J, Langer K. Preparation, characteristics and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles. Int J Pharmaceut, 2007;341:207–14
   PubMed Web of Science ®Google Scholar
• Fanali G, Di Masi A, Trezza V, Marino M, Fasano M, Ascenzi P. Human serum albumin: From bench to bedside. Mol Aspect Med, 2012;33:209–90
   PubMed Web of Science ®Google Scholar
• Gupta PK, Hung CT. Albumin microspheres II: Applications in drug delivery. J Microencapsul, 1989;6:463–72
   PubMed Web of Science ®Google Scholar
• Huang X, El-Sayed Ivan H, Qian W, El-Sayed MA. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J Am Chem Soc, 2006;128:2115–20
   PubMed Web of Science ®Google Scholar
• Huschka R, Zuloaga J, Knight MW, Brown LV, Nordlander P, Halas NJ. Light-induced release of DNA from gold nanoparticles: Nanoshells and nanorods. J Am Chem Soc, 2011;133:12247–55
   PubMed Web of Science ®Google Scholar
• Jang B, Park J, Tung C, Kim I, Choi Y. Gold nanorod-photosensitizer complex for near-infrared fluorescence imaging and photodynamic/photothermal therapy in vivo. ACS Nano, 2011;5:1086–94
   PubMed Web of Science ®Google Scholar
• Jithan A, Madhavi K, Madhavi M, Prabhakar K. Preparation and characterization of albumin nanoparticles encapsulating curcumin intended for the treatment of breast cancer. Int J Pharm Investig, 2011;1:119–25
   PubMedGoogle Scholar
• Jun JY, Nguyen HH, Paik S-Y-R, Chun HS, Kang B-C, Ko S. Preparation of size-controlled bovine serum albumin (BSA) nanoparticles by a modified desolvation method. Food Chem, 2011;127:1892–8
   Web of Science ®Google Scholar
• Kannan R, Nune S, Chanda N, Zambre A, Shukla R. Novel nanochemistry toward generation and stabilization of gold nanoparticles in human serum albumin matrix. Pure Appl Chem, 2011;83:2055–62
   Web of Science ®Google Scholar
• Kim TH, Jiang HH, Youn YS, Park CW, Lim SM, Jin CH, Tak KK, Lee HS, Lee KC. Preparation and characterization of Apo2L/TNF-related apoptosis-inducing ligand-loaded human serum albumin nanoparticles with improved stability and tumor distribution. J Pharm Sci, 2011;100:482–91
   PubMed Web of Science ®Google Scholar
• Koutsoulas C, Pippa N, Demetzos C, Zabka M. The role of ζ-potential on the stability of nanocolloidal systems. Pharmakeutike, 2012;24:106–11
   Google Scholar
• Kufleitner J, Wagner S, Worek F, Von Briesen H, Kreuter J. Adsorption of obidoxime onto human serum albumin nanoparticles: Drug loading, particle size and drug release. J Microencapsul, 2010a;27:506–13
   PubMed Web of Science ®Google Scholar
• Kufleitner J, Worek F, Kreuter J. Incorporation of obidoxime into human serum albumin nanoparticles: Optimisation of preparation parameters for the development of a stable formulation. J Microencapsul, 2010b;27:594–601
   PubMed Web of Science ®Google Scholar
• Langer K, Anhorn MG, Steinhauser I, Dreis S, Celebi D, Schrickel N, Faust S, Vogel V. Human serum albumin (HSA) nanoparticles: Reproducibility of preparation process and kinetics of enzymatic degradation. Int J Pharm, 2008;347:109–17
   PubMed Web of Science ®Google Scholar
• Langer K, Balthasar S, Vogel V, Dinauer N, Von Briesen H, Schubert D. Optimization of the preparation process for human serum albumin (HSA) nanoparticles. Int J Pharmaceut, 2003;257:169–80
   PubMed Web of Science ®Google Scholar
• Lin W, Coombes AGA, Davies MC, Schacht E, Davis SS, Iium L. Preparation of sub-100 nm human serum albumin nanospheres using a pH-coacervation method. J Drug Target, 1993;1:237–43
   PubMed Web of Science ®Google Scholar
• Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review. J Contr Rel, 2000;65:271–84
   PubMed Web of Science ®Google Scholar
• Marty JJ, Oppenheim RC, Speiser P. Nanoparticles-a new colloidal drug delivery system. Pharmaceutica Acta Helvetiae, 1978;53:17–23
   PubMedGoogle Scholar
• Mehravar R, Jahanshah M, Sagatoleslami N. Fabrication and evaluation of human serum albumin (HSA) nanoparticles for drug dlivery application. Int J Nanosci, 2009;8:319–22
   Google Scholar
• Morton JG, Day ES, Halas NJ, West JL. 2010. Nanoshells for photothermal cancer therapy. Cancer nanotechnology; Methods and protocols. New York: Humana Press
   Google Scholar
• Naveenraj S, Anandan S, Kathiravan A, Renganathan R, Ashokkumar M. The interaction of sonochemically synthesized gold nanoparticles with serum albumins. J Pharm Biomed Anal, 2010;53:804–10
   PubMed Web of Science ®Google Scholar
• Nayak NC, Shin K. Human serum albumin mediated self-assembly of gold nanoparticles into hollow spheres. Nanotechnology, 2008;19:265603
   PubMed Web of Science ®Google Scholar
• Preciado-Flores S, Wang D, Wheeler DA, Newhouse R, Hensel JK, Schwartzberg A, Wang L, Zhu J, Barboza-Flores M, Zhang JZ. Highly reproducible synthesis of hollow gold nanospheres with near infrared surface plasmon absorption using PVP as stabilizing agent. J Mater Chem, 2011;21:2344–50
   Web of Science ®Google Scholar
• Sebak S, Mirzaei M, Malhotra M, Kulamarva A, Prakash S. Human serum albumin nanoparticles as an efficient noscapine drug delivery system for potential use in breast cancer: Preparation and in vitro analysis. Int J Nanomed, 2010;5:525–32
   PubMed Web of Science ®Google Scholar
• Sen T, Mandal S, Haldar S, Chattopadhyay K, Patra A. Interaction of gold nanoparticle with human serum albumin (HSA) protein using surface energy transfer. J Phys Chem C, 2011;115:24037–44
   Web of Science ®Google Scholar
• Stone J, Jackson S, Wright D. Biological applications of gold nanorods. Wiley Interdiscip Rev Nanomed Nanobiotechnol, 2011;3:100–9
   PubMed Web of Science ®Google Scholar
• Terentyuk GS, Ivanov AV, Polyanskaya NI, Maksimova IL, Skaptsov AA, Chumakov DS, Khlebtsov BN, Khlebtsov NG. Photothermal effects induced by laser heating of gold nanorods in suspensions and inoculated tumours during in vivo experiments. Quantum Electron, 2012;42:380–9
   Web of Science ®Google Scholar
• Tsai DH, Delrio FW, Keene AM, Tyner KM, Maccuspie RI, Cho TJ, Zachariah MR, Hackley VA. Adsorption and conformation of serum albumin protein on gold nanoparticles investigated using dimensional measurements and in situ spectroscopic methods. Langmuir, 2011;27:2464–77
   PubMed Web of Science ®Google Scholar
• Ulbrich K, Michaelis M, Rothweiler F, Knobloch T, Sithisarn P, Cinatl J, Kreuter J. Interaction of folate-conjugated human serum albumin (HSA) nanoparticles with tumour cells. Int J Pharm, 2011;406:128–34
   PubMed Web of Science ®Google Scholar
• Von Storp B, Engel A, Boeker A, Ploeger M, Langer K. Albumin nanoparticles with predictable size by desolvation procedure. J Microencapsul, 2012;29:138–46
   PubMed Web of Science ®Google Scholar
• Wacker M, Zensi A, Kufleitner J, Ruff A, Schutz J, Stockburger T, Marstaller T, Vogel V. A toolbox for the upscaling of ethanolic human serum albumin (HSA) desolvation. Int J Pharm, 2011;414:225–32
   PubMed Web of Science ®Google Scholar
• Wagner S, Rothweiler F, Anhorn MG, Sauer D, Riemann I, Weiss EC, Katsen-Globa A, Michaelis M, Cinatl JrJ, Schwartz D, et al. Enhanced drug targeting by attachment of an anti αv integrin antibody to doxorubicin loaded human serum albumin nanoparticles. Biomaterials, 2010;31:2388–98
   PubMed Web of Science ®Google Scholar
• Warner S. Diagnostics plus therapy = Theranostics. Scientist, 2004;18:38–9
   Web of Science ®Google Scholar
• Wartlick H, Spänkuch-Schmitt B, Strebhardt K, Kreuter J, Langer K. Tumour cell delivery of antisense oligonuclceotides by human serum albumin nanoparticles. J Control Rel, 2004;96:483–95
   PubMed Web of Science ®Google Scholar
• Webb BA, Chimenti M, Jacobson MP, Barber DL. Dysregulated pH: A perfect storm for cancer progression. Nat Rev Cancer, 2011;11:671–7
   PubMed Web of Science ®Google Scholar
• Weber C, Kreuter J, Langer K. Desolvation process and surface characteristics of HSA nanoparticles. Int J Pharmaceut, 2000;196:197–200
   PubMed Web of Science ®Google Scholar
• Wyatt-Technology. 2011. Wyatt technology corporation handbook. Santa Barbara, CA: Wyatt Technology
   Google Scholar
• Xia Y, Li W, Cobley CM, Chen J, Xia X, Zhang Q, Yang M, Cho E, Brown PK. Gold nanocages: From synthesis to theranostic applications. Acc Chem Res, 2011;44:914–24
   PubMed Web of Science ®Google Scholar
• Yi DK, Sun I, Ryu JH, Koo H, Park CW, Youn I, Choi K, Kwon IC, Kim K, Ahn C. Matrix metalloproteinase sensitive gold nanorod for simultaneous bioimaging and photothermal therapy of cancer. Bioconjugate Chem, 2010;21:2173–7
   PubMed Web of Science ®Google Scholar
• You J, Zhang G, Li C. Exceptionally high payload of doxorubicin in hollow gold nanospheres for near-infrared light-triggered drug release. ACS Nano, 2010;4:1033–41
   PubMed Web of Science ®Google Scholar